Research at Risk

America’s Research Retreat Matters

The U.S. Research Crisis

America’s leading role in the research and development of safe, quality medicines is at risk. This shift is the result of three factors:

Offshore Operations

U.S. policies are causing companies to increasingly move research operations overseas. 

Increased Competition

Foreign countries like China are rapidly growing their biomedical research capabilities.

Unproven Science

Health agencies are moving to replace proven research methods with new approaches that have not been widely validated.

This isn’t just a policy issue—it’s a direct threat to American families’ health and safety.

This causes:

  • Delays in life-saving treatments
  • Dependence on foreign entities
  • Lost confidence in quality and safety
  • Economic and scientific losses
21%

China has surpassed the U.S. in the number of clinical trials conducted each year by over 21 percent.

The Power of the American Gold Standard

Through a legacy of rigorous oversight, careful preclinical research, and a culture that puts patient safety first, America has developed “gold standard science.”

This global biomedical and pharmaceutical leadership gives Americans the confidence that their medicines are proven safe through testing under the world’s highest research standards.

Taking a Stand for Safety Standards

As we work to preserve U.S. biomedical leadership, you can be a part of the solution by getting involved.

Get Involved

Sign up for updates and join the movement to protect 
gold-standard American research and medicines.